原文链接:Softears RSV Review - Headfonia Reviews 原文作者:Berkhan(Headfonia Editor)
We conducted a systematic literature review to understand the occurrences of non-RSV disease and/or non-RSV hospitalizations in published studies of RSV IP. Cochrane, Embase, and PubMed databases were searched and reviewed to summarize data regarding the incidence of RSV and non-RSV respiratory ...
Mineva G, Philip, R. (2022).Impact of Breastfeeding on the Incidence and Severity of RSV Bronchiolitis in Infants: Systematic Review.Pediatrics,149, 280. Mocsny Thomas, S. (2022, October).Respiratory Syncytial Virus (RSV) in Infants.LLL Alliance, ...
Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis. J Infect Dis. 2020;222(Suppl 7): S680-687.编辑于 2023-10-25 15:38・上海...
4. Shi T, Denouel A, Tietjen AK, et al. Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis. J Infect Dis. 2020;222(Suppl 7):S577-S583. doi:10.1093/infdis/jiz059 5. Li Y...
10.Zhang S, et al. Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis. J Infect Dis. 2020;...
历经六十年,RSV疫苗终于上市。今年上半年,美国FDA先后批准GSK和辉瑞的RSV疫苗上市,主要用于60岁以上老年人,且辉瑞的疫苗扩展到妊娠32-36周的孕妇。至此RSV疫苗的百亿蓝海市场角逐战正式打响。 RSV概述 RSV(呼吸道合胞病毒)是一种常见的呼吸道RNA病毒,针对年幼的儿童及60岁以上的老人会导致严重的下呼吸道感染。它包...
Review Manager 5.3用于数据分析。使用固定效应模型进行数据分析,并计算接种疫苗组与未接种疫苗组的相对风险,置信区间为95%。该审查未进行前瞻性登记。 3结果 通过数据库搜索,共发现6306份出版物。重复的出版物和那些不是呼吸道合胞病毒疫苗临床试验的出版物被排除在外。总共收录了38篇出版物,涵盖了四种主要类型的...
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet 2017; 390:946. [8]Widmer K, Zhu Y, Williams JV, et al. Rates of hospitalizations for ...
[14] SUN M, LAI H, NA F, 等. Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children: A Systematic Review and Network Meta-analysis[J/OL]. JAMA network open, 2023, 6(2): e230023. DOI:...